Form 4: AtriCure CFO Angela Wirick Reports Stock Transactions

AtriCure's Chief Financial Officer, Angela Wirick, reported the acquisition and disposal of company stock and the exercise of stock options on March 1, 2024.

Summary

• On March 1, 2024, Angela Wirick, the CFO of AtriCure, Inc., reported transactions involving AtriCure's common stock.
• Wirick acquired 31,008 shares of common stock through a Restricted Stock Award under the 2023 Stock Incentive Plan, vesting annually over three years.
• She also acquired 16,461 shares through the vesting and release of a Performance Share Award under the 2014 Stock Incentive Plan.
• Additionally, Wirick exercised 5,000 non-qualified stock options at a price of $16.95 per share.
• Following these transactions, Wirick beneficially owns 139,070 shares of AtriCure common stock.
• The exercised options were granted on July 28, 2014, and vested over four years.

Sentiment

Score: 6

Explanation: The sentiment is neutral. The filing reflects routine transactions. The exercise of options and vesting of shares are generally positive, but not overwhelmingly so.

Positives

• The vesting of performance shares suggests that the company met certain performance goals.
• The exercise of stock options by the CFO could be interpreted as a positive sign of confidence in the company's future prospects.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the trading activities of company insiders. Investors often monitor these filings to gauge management's sentiment and confidence in the company's performance.

Comparison to Industry Standards

• Insider trading activity is common across publicly listed companies, and the details of these transactions are closely monitored by investors and regulators.
• Comparing the volume and frequency of insider transactions at AtriCure to similar medical device companies like Medtronic or Boston Scientific can provide insights into the relative sentiment of AtriCure's management.

Stakeholder Impact

• The transactions could have a minor impact on shareholder sentiment, depending on how investors interpret the insider activity.
• Employees who hold company stock or options may be interested in the details of these transactions.

Key Dates